Kronox Lab Sciences Ltd

Kronox Lab Sciences Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating upgraded from Sell to Hold as of 17 June 2026. This change reflects a combination of improved technical indicators, solid quarterly financial performance, and a more favourable valuation context despite some lingering concerns over long-term growth. The company’s Mojo Score has risen to 64.0, signalling a cautious but positive outlook for investors.

Kronox Lab Sciences Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a nuanced outlook for investors as the stock price edges higher.

Kronox Lab Sciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Kronox Lab Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Kronox Lab Sciences Ltd., a micro-cap speciality chemicals manufacturer with a market capitalisation of ₹515.75 crores, reported its strongest quarterly profit in Q4 FY26 (January-March 2026), yet the stock's muted response reflects growing investor concerns about the company's anaemic revenue growth trajectory. Net profit surged 21.40% quarter-on-quarter to ₹8.00 crores, marking the highest quarterly profit in company history, whilst operating margins expanded sharply to 36.43%. However, revenue remained flat year-on-year at ₹26.13 crores, exposing the fundamental challenge facing this Ahmedabad-based chemical manufacturer.

Kronox Lab Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with the latest insights into its performance and outlook.

Kronox Lab Sciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trend, and technical outlook.

Kronox Lab Sciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Kronox Lab Sciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Kronox Lab Sciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 April 2026, providing investors with an up-to-date view of its performance and outlook.

The stock of Kronox Lab Sciences Ltd has plunged to an all-time low of Rs. 97.75 on 30 Mar 2026, marking a continuation of a steep decline that has seen the share price fall by nearly 30% year-to-date. This fresh low comes despite the company’s reported financial stability and strong return metrics, highlighting a disconnect between market sentiment and underlying fundamentals.

A sharp decline over the past two sessions has dragged Kronox Lab Sciences Ltd to a fresh 52-week low of Rs 98.45 on 30 Mar 2026, marking a significant 52.5% drop from its peak of Rs 207.40 within the last year.

A sharp decline of 5.04% on 27 Mar 2026 dragged Kronox Lab Sciences Ltd to a fresh 52-week low of Rs 100.75, marking a significant drop from its 52-week high of Rs 207.40. This fall comes amid broader market weakness but also reflects company-specific pressures that have intensified over the past year.